How to interpret the labs IGF-1 trends should be interpreted with age, symptoms, and baseline levels
BPC-157, or Body Protecting Compound-157, is a 15-amino-acid peptide sequence (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) isolated from gastric juices.[1][2] It was first identified in the 1990s as part of research into cytoprotective agents that safeguard the gastrointestinal (GI) tract from damage.[3] Unlike many peptides, BPC-157 is highly stable in acidic environments, allowing for oral administration without significant degradation.[4] In compounding pharmacies, BPC-157 is often prepared as capsules, injectables, or topical formulations
The connection between microbiome and schizophrenia
The steep price for Ozempic and Wegovy could drive some patients to buy counterfeit products online, Kantor said
For example, the likelihood that someone will stop taking tirzepatide or semaglutide because of their side effects is pretty similar, Papamargaritis says, adding that people tend to stick with both drugs at approximately equal rates